Moderation: D. Dobrev (Essen), K. Sattler (Mannheim)
| (BS145) | Chronic kidney disease impairs electrophysiological function and triggers arrhythmias in human myocardium | |
| T. Körtl, N. Hankowitz, O. Pfeuffer, D. Riedl, L. Stengel, S. Pabel, B. Flörchinger, S. Schopka, L. S. Maier, N. Hamdani, K. Streckfuß-Bömeke, S. T. Sossalla (Regensburg, Bochum, Würzburg) | ||
| (BS146) | BMP10: A novel biomarker in atrial fibrillation secreted by atrial cardiomyocytes – Evidence from human experimental models | |
| L. Sommerfeld, C. Espinosa Molina, J. Schrapers, P. Bangfen, G. Höppner, H. Wieboldt, L. Conradi, H. Reichenspurner, T. Eschenhagen, P. Kirchhof, V. Nikolaev, J. Stenzig, L. Fabritz (Hamburg) | ||
| (BS147) | A porcine large animal model of radiofrequency ablation-induced left bundle branch block | |
| M. Jamros, F. Wiedmann, V. Herlt, A. Paasche, L. Weirauch, M. Kraft, M. Beck, M. Stelzle, N. Frey, C. Schmidt (Heidelberg) | ||
| (BS148) | Polycystic kidney disease and atrial arrhythmopathy: mutations in the PKHD1 gene lead to severe changes in atrial action potential formation | |
| L. Weirauch, S. Korkmaz-Icöz, F. Wiedmann, J. Heigwer, P. Kraft, M. Brune, N. Frey, F. Schäfer, C. Schmidt (Heidelberg) | ||
| (BS149) | The potential role of Tmem120a-mediated mechanosensitive currents in the pathophysiology of cardiac arrhythmias | |
| P. Mihaylov, F. Wiedmann, N. Frey, C. Schmidt (Heidelberg) | ||
| (BS150) | Bioresorbable Molybdenum Electrodes: Towards a Novel Generation of Temporary Epicardial Pacing Wires | |
| M.-E. Prieto Jarabo, C. Redlich, A. Schauer, C. Guder, G. Pöhle, T. Weißgärber, V. Adams, U. Kappert, A. El-Armouche, A. Linke, M. Wagner (Dresden) | ||
| (BS151) | Elucidating the genetic network in SHOX2-dependent atrial arrhythmias using human iPSC-derived cardiomyocytes | |
| S. Hoffmann, K. Rädecke, A. Löwen, S. A. Sumer, S. Hücker, F. Zhang, B. Campbell, A. Paasche, A. K. Chan, V. Eckstein, T. Dorn, C. Dieterich, C. Schmidt, S. Kirsch, A. Moretti, G. A. Rappold (Heidelberg, Regensburg, München) | ||
| (BS152) | PDE2 activation as a potential therapeutic strategy to treat diabetic cardiomyopathy-induced arrhythmogenesis | |
| R. Firneburg, E. Cachorro Puente, A. El-Armouche, S. Kämmerer (Dresden) |
